SNORA24 and cancer: Having identified that cancer-associated changes in Snora24 lead to bypass of OIS in the context of oncogenic RAS expression in vivo, we next sought to determine whether reduction of this single H/ACA snoRNA was sufficient to promote tumor development in this model.